Mild cognitive impairment
AM Sanford - Clinics in geriatric medicine, 2017 - geriatric.theclinics.com
Mild cognitive impairment (MCI), first fully characterized by Petersen and associates in 1997,
1 generally refers to impairment in cognition above that which is seen with normal age …
1 generally refers to impairment in cognition above that which is seen with normal age …
Glucose metabolic crosstalk and regulation in brain function and diseases
Brain glucose metabolism, including glycolysis, the pentose phosphate pathway, and
glycogen turnover, produces ATP for energetic support and provides the precursors for the …
glycogen turnover, produces ATP for energetic support and provides the precursors for the …
Glucose transporters at the blood-brain barrier: function, regulation and gateways for drug delivery
SG Patching - Molecular neurobiology, 2017 - Springer
Glucose transporters (GLUTs) at the blood-brain barrier maintain the continuous high
glucose and energy demands of the brain. They also act as therapeutic targets and provide …
glucose and energy demands of the brain. They also act as therapeutic targets and provide …
Positron emission tomography: current challenges and opportunities for technological advances in clinical and preclinical imaging systems
JJ Vaquero, P Kinahan - Annual review of biomedical …, 2015 - annualreviews.org
Positron emission tomography (PET) imaging is based on detecting two time-coincident high-
energy photons from the emission of a positron-emitting radioisotope. The physics of the …
energy photons from the emission of a positron-emitting radioisotope. The physics of the …
Brain PET in the diagnosis of Alzheimer's disease
C Marcus, E Mena, RM Subramaniam - Clinical nuclear medicine, 2014 - journals.lww.com
Objectives The aim of this article was to review the current role of brain PET in the diagnosis
of Alzheimer dementia. The characteristic patterns of glucose metabolism on brain FDG-PET …
of Alzheimer dementia. The characteristic patterns of glucose metabolism on brain FDG-PET …
Imaging and fluid biomarkers in frontotemporal dementia
LH Meeter, LD Kaat, JD Rohrer… - Nature Reviews …, 2017 - nature.com
Frontotemporal dementia (FTD), the second most common type of presenile dementia, is a
heterogeneous neurodegenerative disease characterized by progressive behavioural …
heterogeneous neurodegenerative disease characterized by progressive behavioural …
Systematic review of different neuroimaging correlates in mild cognitive impairment and Alzheimer's disease
P Talwar, S Kushwaha, M Chaturvedi… - Clinical neuroradiology, 2021 - Springer
Alzheimer's disease (AD) is a heterogeneous progressive neurocognitive disorder. Although
different neuroimaging modalities have been used for the identification of early diagnostic …
different neuroimaging modalities have been used for the identification of early diagnostic …
Brain fluorodeoxyglucose (FDG) PET in dementia
T Kato, Y Inui, A Nakamura, K Ito - Ageing research reviews, 2016 - Elsevier
The purpose of this article is to present a selective and concise summary of
fluorodeoxyglucose (FDG) positron emission tomography (PET) in dementia imaging. FDG …
fluorodeoxyglucose (FDG) positron emission tomography (PET) in dementia imaging. FDG …
Neuroimaging and machine learning for dementia diagnosis: recent advancements and future prospects
Dementia, a chronic and progressive cognitive declination of brain function caused by
disease or impairment, is becoming more prevalent due to the aging population. A major …
disease or impairment, is becoming more prevalent due to the aging population. A major …
Roles of O-GlcNAc in chronic diseases of aging
PS Banerjee, O Lagerlöf, GW Hart - Molecular aspects of medicine, 2016 - Elsevier
O-GlcNAcylation, a dynamic nutrient and stress sensitive post-translational modification,
occurs on myriad proteins in the cell nucleus, cytoplasm and mitochondria. O-GlcNAcylation …
occurs on myriad proteins in the cell nucleus, cytoplasm and mitochondria. O-GlcNAcylation …